89 related articles for article (PubMed ID: 15503865)
1. Structural relationships between the insulin receptor and epidermal growth factor receptor families and other proteins.
Ward CW; Garrett TP
Curr Opin Drug Discov Devel; 2004 Sep; 7(5):630-8. PubMed ID: 15503865
[TBL] [Abstract][Full Text] [Related]
2. The insulin and EGF receptor structures: new insights into ligand-induced receptor activation.
Ward CW; Lawrence MC; Streltsov VA; Adams TE; McKern NM
Trends Biochem Sci; 2007 Mar; 32(3):129-37. PubMed ID: 17280834
[TBL] [Abstract][Full Text] [Related]
3. Similar but different: ligand-induced activation of the insulin and epidermal growth factor receptor families.
Ward CW; Lawrence MC
Curr Opin Struct Biol; 2012 Jun; 22(3):360-6. PubMed ID: 22521506
[TBL] [Abstract][Full Text] [Related]
4. Growth factor receptors: structure, mechanism, and drug discovery.
McInnes C; Sykes BD
Biopolymers; 1997; 43(5):339-66. PubMed ID: 9566117
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of the first three domains of the type-1 insulin-like growth factor receptor.
Garrett TP; McKern NM; Lou M; Frenkel MJ; Bentley JD; Lovrecz GO; Elleman TC; Cosgrove LJ; Ward CW
Nature; 1998 Jul; 394(6691):395-9. PubMed ID: 9690478
[TBL] [Abstract][Full Text] [Related]
6. Solution structure of ectodomains of the insulin receptor family: the ectodomain of the type 1 insulin-like growth factor receptor displays asymmetry of ligand binding accompanied by limited conformational change.
Whitten AE; Smith BJ; Menting JG; Margetts MB; McKern NM; Lovrecz GO; Adams TE; Richards K; Bentley JD; Trewhella J; Ward CW; Lawrence MC
J Mol Biol; 2009 Dec; 394(5):878-92. PubMed ID: 19835884
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor receptor as a therapeutic target in head and neck cancer.
Barnes CJ; Ohshiro K; Rayala SK; El-Naggar AK; Kumar R
Clin Cancer Res; 2007 Jul; 13(14):4291-9. PubMed ID: 17634559
[TBL] [Abstract][Full Text] [Related]
8. Active and inactive conformations of the epidermal growth factor receptor.
Ferguson KM
Biochem Soc Trans; 2004 Nov; 32(Pt 5):742-5. PubMed ID: 15494003
[TBL] [Abstract][Full Text] [Related]
9. Co-targeting the EGFR and IGF-IR with anti-EGFR monoclonal antibody ICR62 and the IGF-IR tyrosine kinase inhibitor NVP-AEW541 in colorectal cancer cells.
Cunningham MP; Thomas H; Marks C; Green M; Fan Z; Modjtahedi H
Int J Oncol; 2008 Nov; 33(5):1107-13. PubMed ID: 18949375
[TBL] [Abstract][Full Text] [Related]
10. Insulin receptor structure and its implications for the IGF-1 receptor.
Lawrence MC; McKern NM; Ward CW
Curr Opin Struct Biol; 2007 Dec; 17(6):699-705. PubMed ID: 17851071
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a comparative model of the extracellular domain of the epidermal growth factor receptor.
Jorissen RN; Epa VC; Treutlein HR; Garrett TP; Ward CW; Burgess AW
Protein Sci; 2000 Feb; 9(2):310-24. PubMed ID: 10716183
[TBL] [Abstract][Full Text] [Related]
12. Development of multitargeted inhibitors of both the insulin-like growth factor receptor (IGF-IR) and members of the epidermal growth factor family of receptor tyrosine kinases.
Hubbard RD; Bamaung NY; Fidanze SD; Erickson SA; Palazzo F; Wilsbacher JL; Zhang Q; Tucker LA; Hu X; Kovar P; Osterling DJ; Johnson EF; Bouska J; Wang J; Davidsen SK; Bell RL; Sheppard GS
Bioorg Med Chem Lett; 2009 Mar; 19(6):1718-21. PubMed ID: 19217287
[TBL] [Abstract][Full Text] [Related]
13. Nimotuzumab, an antitumor antibody that targets the epidermal growth factor receptor, blocks ligand binding while permitting the active receptor conformation.
Talavera A; Friemann R; Gómez-Puerta S; Martinez-Fleites C; Garrido G; Rabasa A; López-Requena A; Pupo A; Johansen RF; Sánchez O; Krengel U; Moreno E
Cancer Res; 2009 Jul; 69(14):5851-9. PubMed ID: 19584289
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor (EGFR) signaling in cancer.
Normanno N; De Luca A; Bianco C; Strizzi L; Mancino M; Maiello MR; Carotenuto A; De Feo G; Caponigro F; Salomon DS
Gene; 2006 Jan; 366(1):2-16. PubMed ID: 16377102
[TBL] [Abstract][Full Text] [Related]
15. Structure of the extracellular region of HER3 reveals an interdomain tether.
Cho HS; Leahy DJ
Science; 2002 Aug; 297(5585):1330-3. PubMed ID: 12154198
[TBL] [Abstract][Full Text] [Related]
16. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
Huang Y; Li X; Jiang J; Frank SJ
Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
[TBL] [Abstract][Full Text] [Related]
17. Dual silencing of type 1 insulin-like growth factor and epidermal growth factor receptors to induce apoptosis of nasopharyngeal cancer cells.
Yuan YL; Zhou XH; Song J; Qiu XP; Li J; Ye LF
J Laryngol Otol; 2008 Sep; 122(9):952-60. PubMed ID: 17908353
[TBL] [Abstract][Full Text] [Related]
18. Structure of the insulin receptor ectodomain reveals a folded-over conformation.
McKern NM; Lawrence MC; Streltsov VA; Lou MZ; Adams TE; Lovrecz GO; Elleman TC; Richards KM; Bentley JD; Pilling PA; Hoyne PA; Cartledge KA; Pham TM; Lewis JL; Sankovich SE; Stoichevska V; Da Silva E; Robinson CP; Frenkel MJ; Sparrow LG; Fernley RT; Epa VC; Ward CW
Nature; 2006 Sep; 443(7108):218-21. PubMed ID: 16957736
[TBL] [Abstract][Full Text] [Related]
19. Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells.
Johnson FM; Saigal B; Donato NJ
J Cell Physiol; 2005 Nov; 205(2):218-27. PubMed ID: 15887238
[TBL] [Abstract][Full Text] [Related]
20. Structural insights into ligand-induced activation of the insulin receptor.
Ward C; Lawrence M; Streltsov V; Garrett T; McKern N; Lou MZ; Lovrecz G; Adams T
Acta Physiol (Oxf); 2008 Jan; 192(1):3-9. PubMed ID: 18171424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
